In this study, we first established a chronic and progressive colitis model by administration of increasing concentrations of DSS during a period of 28 days and compared the response between knock-in mice carrying the G2019S LRRK2 mutation (GS LRRK2) and control wild-type mice (WT LRRK2) (Fig. 1a). Here, LRRK2 is linked to colitis.